Sequel Pharmaceuticals (India) Private Limited
About Sequel Pharmaceuticals (India) Private Limited
Data last updated:
Sequel Pharmaceuticals (India) Private Limited is a private limited company based in Ambernath, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 June 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2006PTC162896. The company has 3 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.8 Cr. It was formerly known as Sequel Pharmachem Private Limited and Sequel Pharmaceuticals Private Limited. It is led by directors Ramchandra Haridas Parade and Nandadip Sakharam Rasam.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at N – 46 Ambernath MIDC Anand Nagar, Maharashtra, India – 421504.
As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹36.09 Cr on record. Court records list 17 cases involving the company, including 17 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Sequel Pharmaceuticals (India) has undergone 2 name changes throughout its history. The company was previously known as Sequel Pharmachem Private Limited, and Sequel Pharmaceuticals Private Limited. The current legal name is Sequel Pharmaceuticals (India) Private Limited.
| Company Name | Status |
|---|---|
| Sequel Pharmaceuticals (India) Private Limited | Current |
| Sequel Pharmachem Private Limited | Previous |
| Sequel Pharmaceuticals Private Limited | Previous |
Contact details
Sequel Pharmaceuticals (India) Private Limited's registered office is in Ambernath, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressN – 46 Ambernath MIDC Anand Nagar, Maharashtra, India – 421504
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sequel Pharmaceuticals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sequel Pharmaceuticals (India) Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sequel Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Sequel Pharmaceuticals (India) Private Limited
Sequel Pharmaceuticals (India) has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramchandra Haridas Parade | Director | 18 Jun 2020 | 6 Years 4 Months | Current |
| Nandadip Sakharam Rasam | Director | 06 May 2023 | 3 Years 5 Months | Current |
Auditor
Sequel Pharmaceuticals (India) Private Limited is audited by Prakash Ravatale & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Prakash Ravatale & Associates | FY 2023 | 135463W |
Shareholding
The shareholding of Sequel Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sequel Pharmaceuticals (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Apr 2011 | 10288388 | Nkgsb Co-Op. Bank Ltd. | ₹5 Cr | Open | |
| 22 Dec 2007 | 10089461 | Corporation Bank | ₹29.31 Cr | Satisfied | |
| 10 Aug 2007 | 10063597 | Janakalyan Sahakari Bank Ltd. | ₹4.18 Cr | Satisfied | |
| 12 Apr 2007 | 10096643 | Janakalyan Sahakari Bank Limited | ₹1.6 Cr | Satisfied | |
| 12 Apr 2007 | 10093608 | Janakalyan Sahakari Bank Ltd. | ₹1 Cr | Satisfied |
To see the full charge records of Sequel Pharmaceuticals (India) Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Sequel Pharmaceuticals (India) Private Limited has 17 court cases on record: 17 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 12 | 0 |
| High courts | 5 | 5 | 0 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed against the company by Pearl Polymers Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by Registrar of Companies | Disposed |
| District court, Thane, Maharashtra | Court case (Reg Dkst) | Filed against the company by Nkgsb Co-Operative Bank Limited | Disposed |
| District court, Thane, Maharashtra | Arbitration matter | Filed against the company by Nkgsb Co-Operative Bank Limited | Disposed |
| Bombay High Court | Court case (OLR) | Filed against the company by The Official Liquidator High Court Bombay | Disposed |
To see the full case history of Sequel Pharmaceuticals (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sequel Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sequel Pharmaceuticals (India) has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sequel Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Sequel Pharmaceuticals (India) Private Limited has 8 board changes on record since 2008: 2 appointments and 6 cessations. The latest: Santosh Shrikrishna Joshi ceased to be Director on 08 May 2023.
12 earlier events are in the company report.
Frequently asked questions
Sequel Pharmaceuticals (India) is an active private limited company based in Ambernath, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 June 2006 (20+ years old) and is registered under CIN U24239MH2006PTC162896.
Sequel Pharmaceuticals (India) has 2 current directors:
- Ramchandra Haridas Parade - Director
- Nandadip Sakharam Rasam - Director
The latest financial statements of Sequel Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Sequel Pharmaceuticals (India) has 3 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Sequel Pharmaceuticals (India) is U24239MH2006PTC162896. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sequel Pharmaceuticals (India) has 17 court cases on record: 17 filed against it. Most are in the district courts.
Sequel Pharmaceuticals (India) was incorporated on 28 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Santosh Shrikrishna Joshi ceased to be Director on 08 May 2023. Nandadip Sakharam Rasam was appointed as Director on 06 May 2023. Mohan Kashiram Kadam ceased to be Director on 19 Jun 2020. Sequel Pharmaceuticals (India) has 8 board changes on record in total.
The registered office of Sequel Pharmaceuticals (India) is at N – 46 Ambernath MIDC Anand Nagar, Maharashtra, India – 421504.
Sequel Pharmaceuticals (India) operates in the pharma industry, in the drug formulation and development segment.